|
Businessmen of
Hyd |
|
Mr.K.C.K.A.Gupta
Chairman, Ocean Park
Mr. Ramesh Datla,Elico
T.Muralidharan,
Chairman,TMI Network
Dr S P Vasireddi
MD,Vimta Labs
Mr.Narendra Paruchuri
CEO,
Pragati
Mr.C.V.Rao
MD, Image Hospitals
Mr. Sudhir Rao
MD, Bartronics India
Dr.Krishna
M.Ella
CMD, Bharat Biotech
Mr.SK Anjaneyulu
Mahendra &
Ravinder Agarwal
Mr. Murali Mohan,
Mr. A.Ramesh
Prasad
PR Agarwal
Mr.Rameshwara Rao
The Dharod Brother
Mr
Murali K Divi
Mr.
Bhasker Reddy
Mr.Sree Duddilla
Mr. N. Jaiveer Reddy
N.Nageswar Rao
Mr A.Krishna Prasad
Mr.
J.Laxman Rao
Mr.Venkat Jasti
Mr.G.M.Surana
Mr.Gautam Chand Jain
Mr. Varaprasad Reddy
Mr..Mohan.Reddy,
Mr.K.
Prasad,
Mr.Hemant
Savla
J. Raghavendra,
Mr.Ghaisuddin Babukhan
Col Narne Ranga Rao
|
|
Businessman
of 2001
Dr.Anji Reddy,
Dr.Reddy Labs |
|
|
|
Mr. B. ParthaSaradhi
Reddy
Managing Director, Hetero Drugs
Ltd. |
|
Hyderabad, August' 04:
Hyderabad-based Pharma company
Hetero Drugs Ltd, A relatively
young company in the Indian
Pharmaceutical Industry is
making rapid strides both
nationally and internationally.
Involved in the manufacture of
active pharmaceutical
ingredients and finished dosage
forms, Hetero is one of the very
few companies which have been
able to carve a niche in the
market given the present
|
 |
scenario where it requires
intellectual strength, core
competencies and
the right vision for the future. |
Hetero has come a long way since
its incorporation in the year 1993
to be recognized as a strong player
in the field of pharmaceuticals, as
a result of its combined strength in
research, manufacture and marketing.
With full-fledged marketing
capabilities, the company has been
able to market its products in over
80 countries in Asia, Middle-east,
Eastern Europe and Latin America.
With it's compliance to the most
stringent regulatory requirements,
Hetero has today gained foothold to
market several of its APIs in the
United States, Canada and Europe.
With all six manufacturing
facilities being supported by
excellent infrastructure and
compliance to the GMP requirements ,
Hetero has crossed numerous
milestones in a comparatively small
period since its inception.
Hetero Drugs Ltd has been chosen by
the Clinton Research Foundation as
one of the four Indian
pharmaceutical companies that would
supply HIV/AIDS drugs to four
African and nine Caribbean nations.
HDL range of three drug
combinations, namely 'Nevirapine', 'Lamivudine',
'Stavudine', were available at a
price that AIDS patients in India
could afford
The spirit and brain behind the
success story of Hetero is its
founder Dr.BPS Reddy, a Scientist
who started the company drawing
immense strength from the vast and
rich experience he gained during his
earlier stint at the Laboratory
where he was instrumental in
developing and commercializing
processes for several APIs .
The Company was started by him with
with a vision to be recognised as an
aggressive company that combines its
strength of R&D and manufacturing
with definite advantages in terms of
cost and chemistry with a strong
emphasis on Quality of the products.
The untiring efforts of the Chairman
saw Hetero develop processes for
several products at relatively low
cost, thus making it possible for
several life saving drugs to be
available at affordable prices,
meeting all the Regulatory and
Quality norms.
With the organisation having reached
a point where it is identified among
the widely recognised companies, the
Chairman is now focusing on giving
new dimensions to the company in
terms of exploring possibilities of
further growth, exploring new
horizons in the field of
Pharmaceutical development and
evolving strategies to take the
company to greater heights.
Dr.B. ParthaSaradhi Reddy the Vice
President of Bulk Drug Manufacturers
Association of India.
|
August' 2004
Reachout's News Bureau
|
|
|